Preferred Label : erenumab;

CISMeF synonym : AMG 334;

UNII : I5I8VB78VT;

Details


Main resources

You can consult :


https://www.cbip.be/fr/articles/3752?folia=3740
2022
false
false
false
Belgium
French
journal article
raynaud phenomenon
migraine disorders
erenumab
fremanezumab
galcanezumab
calcitonin gene-related peptide
cohort studies
Calcitonin gene-related peptide (CGRP) antagonists
disease progression

---
https://www.has-sante.fr/jcms/p_3330875/fr/aimovig-erenumab-migraine
2022
France
evaluation of the transparency committee
erenumab
Aimovig
migraine, nos
Migraine
migraine disorders
migraine
erenumab

---
https://www.cbip.be/fr/articles/3662?folia=3658
2021
false
false
false
Belgium
French
journal article
drug information
antibodies, monoclonal, humanized
migraine disorders
antibodies, monoclonal
belgium
calcitonin gene-related peptide
erenumab
fremanezumab
galcanezumab

---
https://www.has-sante.fr/portail/jcms/c_2908652/fr/aimovig
2019
false
true
false
false
France
treatment outcome
insurance, health, reimbursement
erenumab
erenumab
injections, subcutaneous
migraine disorders
adult
erenumab
evaluation of the transparency committee
antibodies, monoclonal
antibodies, monoclonal

---
https://www.has-sante.fr/jcms/p_3108955/fr/aimovig
2019
false
false
false
France
erenumab
evaluation of the transparency committee
antibodies, monoclonal

---
Aimovig erenumab
https://www.ema.europa.eu/medicines/human/EPAR/Aimovig
2018
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
erenumab
erenumab
drug approval
europe
adult
migraine disorders
injections, subcutaneous
product surveillance, postmarketing
antibodies, monoclonal
antibodies, monoclonal
aged
drug interactions
pregnancy
chronic disease
drug evaluation, preclinical
erenumab
Calcitonin Gene-Related Peptide Receptor Antagonists
Calcitonin Gene-Related Peptide Receptor Antagonists

---
Nous contacter.
03/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.